Press release
Long-Acting Reversible Contraception(LARC) Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports
Long-Acting Reversible Contraception(LARC) Market SizeAccording to new survey, global Long-Acting Reversible Contraception(LARC) market is projected to reach US$ 1730.6 million in 2029, increasing from US$ 1154 million in 2022, with the CAGR of 6.0% during the period of 2023 to 2029.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-20M15682/Global_Long_Acting_Reversible_Contraception_LARC_Market_Research_Report_2023
Long-Acting Reversible Contraception(LARC) Market
Long-acting reversible pregnancy (LARC) is a birth control method that provides long-term pregnancy prevention. LARC can provide protection for three to 10 years or more.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Long-Acting Reversible Contraception(LARC) market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-20M15682/Global_Long_Acting_Reversible_Contraception_LARC_Market_Research_Report_2023
Segment by Type
• Intrauterine Devices (IUCs)
• Subcutaneous Implant
Segment by Application
• Age 20~24 Years Old
• Age 25-34 Years Old
• Age 35~44 Years Old
• Other
By Company
Bayer, Merck, Teva Pharmaceutical, Allergan, HRA Pharma, Eurogine, Yantai Family Planning Pharmaceutical Equipment Co., Ltd., Wuxi Tianyi Medical Equipment Co., Ltd., SMB Corporation, Shenyang Liren, Tianjin Hejie Medical Equipment Co., Ltd., Cooper Companies, AbbVie Allergan, Organon, Shanghai Dahua Pharmaceutical
View full report
https://reports.valuates.com/market-reports/QYRE-Auto-20M15682/global-long-acting-reversible-contraception-larc
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Long-Acting Reversible Contraception(LARC) Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports here
News-ID: 3455339 • Views: …
More Releases from Valuates Reports
Bio-FET Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Va …
Bio-FET Market Size
The global Bio-FET market was valued at US$ 34 million in 2023 and is anticipated to reach US$ 205.3 million by 2030, witnessing a CAGR of 30.8% during the forecast period 2024-2030.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-19C12429/Global_Bio_FET_Market_Research_Report_2022
Report Scope
The Bio-FET market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from…
Children's Smartphone Market: Size, Share, Growth, Analysis, Key Players, Revenu …
Global Children's Smartphone Market
The global Children's Smartphone market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Children's Smartphone is estimated to increase from $ million in 2023 to reach $ million by 2029, at a…
Broadband Ocean Bottom Seismometer Market: Size, Share, Growth, Analysis, Key Pl …
Broadband Ocean Bottom Seismometer Market
Broadband Ocean Bottom Seismometers provide characterization of seismicity/earthquake activity along tectonic plate boundaries where two key phenomena can occur: large-magnitude subduction zone earthquakes and seismicity associated with migration of melt (magma) beneath the seafloor at underwater volcanoes. Because the seismometers are cabled and, hence, connected directly to shore, they can provide detection of earthquakes in real-time.
According to new survey, global Broadband Ocean Bottom Seismometer market is…
Gemtuzumab Ozogamicin Market: Size, Share, Growth, Analysis, Key Players, Revenu …
Gemtuzumab Ozogamicin Market Size
The global Gemtuzumab Ozogamicin market was valued at US$ 214.3 million in 2023 and is anticipated to reach US$ 179.5 million by 2030, witnessing a CAGR of -2.5% during the forecast period 2024-2030.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-16P2766/COVID_19_Impact_on_Gemtuzumab_Ozogamicin_Market_Global_Research_Reports_2020_2021
Report Scope
The Gemtuzumab Ozogamicin market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for…
More Releases for LARC
Intrauterine Devices (IUDs) Market Report: Analyzing Effective Business Strategi …
An intrauterine device (IUD), also known as intrauterine contraceptive device (IUCD or ICD) or coil, is a small, often T-shaped birth control device that is inserted into the uterus to prevent pregnancy. IUDs are one form of long-acting reversible birth control (LARC). One study found that female family planning providers choose LARC methods more often (41.7%) than the general public (12.1%). Among birth control methods, IUDs, along with other contraceptive…
Global Intrauterine Devices (IUD) Market Report 2020, COVID-19 Impact, Market Tr …
According to the recent report by IMARC Group, titled “Intrauterine Devices (IUD) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,” the global intrauterine device market size reached US$ 4 Billion in 2019. Intrauterine devices (IUDs) are small T-shaped contraceptive devices which are placed in the uterus to prevent the implantation of fertilized ova. They are a form of long-acting reversible contraceptives (LARC) which help in birth control.…
Intrauterine Contraceptive Devices Market Latest Trends By Market Analysis with …
Intrauterine contraceptive devices - a way of birth control for a prolonged period
Intrauterine contraceptive devices (IUD), often found in T-shape, are inserted in the uterus in order to prevent conception. The arms of the device are fold flat helping to insert inside the womb and its size is like a match stick, so that it fits properly inside the womb. These devices include either copper or levonorgestrel, which helps in…
Contraceptive Drugs and Devices Market 2027 – Choice to Conceive, Not Concede …
Demand for advanced contraceptive options such as IUD, injectables, implants and diaphragms is observed to be high globally. This is owing to growing awareness among the populace, availability of reimbursement and growing demand for long term contraceptive methods. Government promotes the use of IUD and implants i.e. long-acting contraceptives for better therapeutic effect and safety. Also, reimbursement schemes are made attractive for consumers to opt for these contraceptive methods.
Companies present…
U.S. Contraceptives Drug and Devices Market to Patent Expiries Leading to Plumme …
Companies present in the contraceptives market prefer marketing oral contraceptive pills to churn out considerable and constant revenues compared to one-time revenue generated through long-acting contraceptives. Moreover, there is heavy promotion of oral pills compared to the long acting contraceptives such as IUD, and implant. This has kept the consumers away from the real benefits of long acting contraceptives over the oral pills. This is the reason that oral pills…
Contraceptives Drugs And Devices Market Projected to Experience Major Revenue Bo …
Contraceptive drugs and devices that aid to control birth rate and unintended pregnancies are subject to unique regulatory challenges across different countries. For instance, contraceptive drugs and devices face reimbursement challenges in the U.S., while contraceptive pills face advertising restrictions in India. Owing to this, contraceptives preference greatly various across countries. Statistics revealed by the United Nations in 2015, highlight this trends, with a particular contraceptive accounting for over 50%…
